SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-103561
Filing Date
2022-04-13
Accepted
2022-04-13 06:09:33
Documents
17
Period of Report
2022-04-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d350637d8k.htm   iXBRL 8-K 47830
2 EX-2.1 d350637dex21.htm EX-2.1 500438
3 EX-10.1 d350637dex101.htm EX-10.1 61493
4 EX-99.1 d350637dex991.htm EX-99.1 42120
8 GRAPHIC g350637dsp110.jpg GRAPHIC 7756
9 GRAPHIC g350637dsp111.jpg GRAPHIC 4346
  Complete submission text file 0001193125-22-103561.txt   947286

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA srra-20220412.xsd EX-101.SCH 2866
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20220412_lab.xml EX-101.LAB 17995
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20220412_pre.xml EX-101.PRE 11268
11 EXTRACTED XBRL INSTANCE DOCUMENT d350637d8k_htm.xml XML 3339
Mailing Address 1820 GATEWAY DRIVE SUITE 110 SAN MATEO CA 94404
Business Address 1820 GATEWAY DRIVE SUITE 110 SAN MATEO CA 94404 (605) 376-8679
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37490 | Film No.: 22823585
SIC: 2834 Pharmaceutical Preparations